# Diagnostic Contribution, Prognosis and Physiopathological Aspects in Arrhythmogenic Cardiomyopathy. (ACORE)

> **NCT05569356** · — · NOT_YET_RECRUITING · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 300 (estimated)

## Conditions studied

- Arrhythmogenic Cardiomyopathy

## Interventions

- **BIOLOGICAL:** Prospective
- **OTHER:** Retrospective

## Key facts

- **NCT ID:** NCT05569356
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2022-10-20
- **Primary completion:** 2032-10-20
- **Final completion:** 2032-10-20
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2022-10-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05569356

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05569356, "Diagnostic Contribution, Prognosis and Physiopathological Aspects in Arrhythmogenic Cardiomyopathy. (ACORE)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05569356. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*